Back

AI drug race shifts from candidate discovery to proving medicines work

Verifying
  • Novorex tested AI-selected drug candidates in its North Jeolla laboratory.
  • NRX-NGT002 required 186 synthesized compounds, versus roughly 2,000 conventionally.
  • Novorex targets global clinical trials by year-end for NRX-NGT002.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.